We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational analysis uncovers hematologic adverse events in patients using trastuzumab deruxtecan, indicating safety concerns.
No takes yet. Share an insight, caveat, or question.
Kanbayashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: